Warning: Illegal string offset 'EN' in /var/www/web215/htdocs/findmulti/languages/en/terms.inc on line 1190 Warning: Illegal string offset 'EN' in /var/www/web215/htdocs/findmulti/languages/en/terms.inc on line 1194 Supplier Profile | Expression Analysis, Inc.

Company Profile: Expression Analysis, Inc.

General Profile | Applications
Company logo & address


Expression Analysis, Inc.
4324 South Alston Avenue
27713 Durham
United States
Company view & branch

Dummy company view placeholder

Expression Analysis, Inc. is a leading provider of genomics services to the pharmaceutical, biotechnology, academic, government and non-profit markets. We provide a full range of solutions in support of our clients’ clinical trial and research efforts, including experiment design, sample analysis, nucleic acid isolation, gene expression profiling, genotyping, next generation sequencing and advanced bioinformatics.

Products & special subjects

Expression Analysis provides whole genome to focused set gene expression and genotyping assays along with DNA sequencings services, sequence enrichment technologies and bioinformatics support. Platforms utilized include Affymetrix GeneChip® and GeneTitan®, Applied Biosystems’ Taqman, Illumina BeadChip and Genome Analyzer, Nanostring and RainDance Technology. Expression Analysis offers solutions for challenging specimens such as whole blood and FFPE tissues, as well as nucleic acid isolation and data analysis services. Our quality system follows CLSI guidelines and our CLIA-registered laboratory supports GLP compliance.

Company history

Expression Analysis was incorporated in August 2001 as the commercialization of the Microarray Core Facility at Duke University Medical Center. The Company’s initial focus was to provide high quality, high throughput microarray testing services on a single platform. Today, we offer a broad range of services across multiple platforms, including Affymetrix, Applied Biosystems, Illumina, Luminex Nanostring and RainDance Technologies. Our customers include eight of the ten largest pharmaceutical companies, numerous small to midsize biotechnology and diagnostic firms, multiple branches of government, and many leading research institutions.

Expression Analysis provides its services in compliance with 21 CFR Part 58 (Good Laboratory Practices) and maintains a robust quality system. Additionally, we have registered to obtain CLIA certification under 42 CFR Part 493, and expect to be certified by the end of 2009. CLIA certification will enable us to expand our service offerings to allow for the laboratory testing of human samples used in clinical and diagnostic applications.

Expression Analysis is located in the Research Triangle region of North Carolina.